Synthesis of ester and amide derivatives of 1-phenyl-3-(thiophen-3-yl)-1H- pyrazole-4-carboxylic acid and study of their anticancer activity

Medicinal Chemistry Research

Volumn 22, Issue 7, 2013, Pages 3109-3118

  Inceler, Nazan ^a   Yilmaz, Akin ^a   Baytas, Sultan Nacak ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

1H Pyrazoles; Anticancer activity; MTT; Synthesis; Thiophene

Indexed keywords

(4 BENZYLPIPERIDIN 1 YL)(1 PHENYL 3 (THIOPHEN 3 YL) 1H PYRAZOL 4 YL) METHANONE; [1 PHENYL 3 (THIOPHEN 3 YL) 1H PYRAZOL 4 YL)(4 (4 TRIFLUOROMETHYLPHENYL) PIPERAZIN 1 YL] METHANONE; AMIDE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HL 60; CELL STRAIN MCF 7; COMPUTER MODEL; DRUG SYNTHESIS; HELA CELL; HUMAN; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; RAJI CELL;

EID: 84878892493     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0317-2     Document Type: Article

References (62)

1. Abdel-Aziz M, Abuo-Rahma GEA, Hassan AA (2009) Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur J Med Chem 44:3480-3487
2. Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AA-M, El-Azab AS, Al-Khamees HA, El-Subbagh HI (2009) Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem 44:2379-2391
3. Anzaldi M, Macciò C, Mazzei M, Bertolotto M, Ottonello L, Dallegri F, Balbi A (2009) Antiproliferative and proapoptotic activities of a new class of pyrazole derivatives in HL-60 cells. Chem Biodivers 6:1674-1687
4. Arbaciauskiene E, Martynaitis V, Krikstolaityte S, Holzer W, Sackus A (2011) Synthesis of 3-substituted 1-phenyl-1H-pyrazole-4-carbaldehydes and the corresponding ethanones by Pd-catalyzed cross-coupling reactions. ARKIVOC 11:1-21
5. Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN (2009) Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg Med Chem 17:8168-8173
6. Barresi V, Condorelli DF, Fortuna CG, Musumarra G, Scire S (2002) In vitro antitumor activities of 2,6-di-[2-(Heteroaryl)vinyl]pyridines and pyridiniums. Bioorg Med Chem 10:2899-2904
7. Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong B-S, Jahng Y, Na Y, Cho W-J, Kwon Y, Lee C-S, Lee E-S (2010) 2,6-Dithienyl-4-furyl pyridines: synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. Bioorg Med Chem Lett 20:42-47
8. Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26:331-345
9. Chou L-C, Huang L-J, Yang J-S, Lee F-Y, Teng C-M, Kuo S-C (2007) Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl) indazole (YC-1) as novel anti-leukemia agents. Bioorg Med Chem 15:1732-1740
10. Chou LC, Huang LJ, Hsu MH, Fang MC, Yang JS, Zhuang SH, Lin HY, Lee FY, Teng CM, Kuo SC (2010) Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl) selenolo[3,2-c]pyrazole derivatives as new anticancer agents. Eur J Med Chem 45:1395-1402
11. Christodoulou MS, Liekens S, Kasiotis KM, Haroutounian SA (2010) Novel pyrazole derivatives: synthesis and evaluation of anti-angiogenic activity. Bioorg Med Chem 18:4338-4350
12. Cozzi P (2003) The discovery of a new potential anticancer drug: a case history. Farmaco 58:213-220
13. Daidone G, Maggio B, Raffa D, Plescia S, Schillaci D, Raimondi MV (2004) Synthesis and in vitro antileukemic activity of new 4-triazenopyrazole derivatives. Farmaco 59:413-417
14. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277
15. Ding X-L, Meng N, Xia Y, Wang L-J, Zhang X-F, Zhao B-X, Miao J-Y (2007) Synthesis of 3-phenyl-1-[(aryl)methyl]-1H-pyrazole-5-carboxylic acid ethyl ester derivatives and determination of their activity as promoters of cell apoptosis. Youji Huaxue 27:1542-1546
16. El-Shafei A, Fadda AA, Khalil AM, Ameen TAE, Badria FA (2009) Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs. Bioorg Med Chem 17:5096-5105
17. Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714-3717
18. Gaston MA, Dias LRS, Freitas ACC, Miranda ALP, Barreiro EJ (1996) Synthesis and analgesic properties of new 4-arylhydrazone 1-H pyrazole [3,4-b]pyridine derivatives. Pharm Acta Helv 71:213-219
19. GraphPad Prism Version 5.04 for Windows (2010) GS, San Diego. www.graphpad.com
20. Gouda MA, Berghot MA, Shoeib AI, Khalil AM (2010) Synthesis and antimicrobial activity of new anthraquinone derivatives incorporating pyrazole moiety. Eur J Med Chem 45:1843-1848
21. Holst-Hansen C, Brünner N (1998) MTT-cell proliferation assay. In: Celis JE (ed) Cell Biology: a Laboratory Handbook, 2nd edn. Academic Press, San Diego, pp 16-18
22. http://www.molinspiration.com/cgi-bin/properties
23. http://www.organic-chemistry.org/prog/peo
24. Hu WP, Yu HS, Chen YR, Tsai YM, Chen YK, Liao CC, Chang LS, Wang JJ (2008) Synthesis and biological evaluation of thiobenzanilides as anticancer agents. Bioorg Med Chem 16:5295-5302
25. Huang S, Lin R, Yu Y, Lu Y, Connolly PJ, Chiu G, Li S, Emanuel SL, Middleton SA (2007) Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4- ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor. Bioorg Med Chem Lett 17:1243-1245
26. Insuasty B, Orozco F, Quiroga J, Abonia R, Nogueras M, Cobo J (2008) Microwave induced synthesis of novel 8,9-dihydro-7H-pyrimido[4,5-b][1,4] diazepines as potential antitumor agents. Eur J Med Chem 43:1955-1962
27. Insuasty B, Chamizo L, Munoz J, Tigreros A, Quiroga J, Abonia R, Nogueras M, Cobo J (2011) Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2- pyrazolines and study of their antitumor activity. Arch Pharm Chem Life Sci 345:275-286
28. Johnsto SRD, Ford H, Ross P (2005) In the royal marsden hospital hand book of cancer chemotherapy. Elsevier, London, New York, Oxford
29. Kemnitzer W, Jiang S, Wang Y, Kasibhatla S, Crogan-Grundy C, Bubenik M, Labrecque D, Denis R, Lamothe S, Attardo G, Gourdeau H, Tseng B, Drewe J, Cai SX (2008) Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Part 5. Modifications of the 2- and 3-positions. Bioorg Med Chem Lett 18:603-607
30. Kim DSHL, Ashendel CL, Zhou Q, Chang CT, Lee E-S, Chang CJ (1998) Novel protein kinase c inhibitors: α-terthiophene derivatives. Bioorg Med Chem Lett 8:2695-2698
31. Kueng W, Silber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Anal Biochem 182:16-19
32. Lee ER, Kang YJ, Choi HY, Kang GH, Kim JH, Kim BW, Han YS, Nah SY, Paik HD, Park YS, Cho SG (2007) Induction of apoptotic cell death by synthetic naringenin derivatives in human lung epithelial carcinoma A549 cells. Biol Pharm Bull 30:2394-2398
33. Leite ACL, da Silva KP, de Souza IA, de Araujo JM, Brondani DJ (2004) Synthesis, antitumor and antimicrobial activities of new peptidyl derivatives containing the 1,3-benzodioxole system. Eur J Med Chem 39:1059-1065
34. Li J, Zhao YF, Zhao XL, Yuan XY, Gong P (2006) Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines. Arch Pharm Chem Life Sci 339:593-597
35. Lian S, Su H, Zhao B-X, Liu W-Y, Zheng L-W, Miao J-Y (2009) Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Bioorg Med Chem 17:7085-7092
36. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26
37. Lv PC, Sun J, Luo Y, Yang Y, Zhu HL (2010) Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. Bioorg Med Chem Lett 20:4657-4660
38. Machado P, Campos PT, Lima GR, Rosa FA, Flores AFC, Bonacorso HG, Zanatta N, Martins MAP (2009) Experimental and calculated structural parameters of 5-trihalomethyl-4,5-dihydro-1H-pyrazole derivatives, novel analgesic agents. J Mol Struct 917:176-182
39. Micale N, Zappala M, Grasso S (2002) Synthesis and antitumor activity of 1,3-benzodioxole derivatives. Farmaco 57:853-859
40. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
41. Nagarapu L, Mateti J, Gaikwad HK, Bantu R, Rani MS, Subhashini NJP (2011) Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4- phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives. Bioorg Med Chem Lett 21:4138-4140
42. Padmaja A, Payani T, Reddy DG, Padmavathi V (2009) Synthesis, antimicrobial and antioxidant activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives. Eur J Med Chem 44:4557-4566
43. Pan XH, Liu X, Zhao BX, Xie YS, Shin DS, Zhang SL, Zhao J, Miao JY (2008) 5-Alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives inhibit growth of lung cancer A549 cell by inducing apoptosis. Bioorg Med Chem 16:9093-9100
44. Reile H, Birnbock H, Bernhardt G, Spruss T, Schonenberger H (1990) Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem 187:262-267
45. Riyadh SM, Farghaly TA, Abdallah MA, Abdallah MM, Abd El-Aziz MR (2010) New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity. Eur J Med Chem 45:1042-1050
46. Schenone S, Bruno O, Ranise A, Bondavalli F, Brullo C, Fossa P, Mosti L, Menozzi G, Carraro F, Naldini A, Bernini C, Manettic F, Botta M (2004) New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation. Bioorg Med Chem Lett 14:2511-2517
47. Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW (2000) Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82:1459-1468
48. Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, Wu MS, Yeh JY, Chao YS, Hsu JT, Hsieh HP, Horng JT (2010) Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci 17:13-21
49. Silveira IAFB, Paulo LG, Miranda ALP, Rocha SO, Freita ACC, Barreiro EJ (1993) New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation. J Pharm Pharmacol 45:646-649
50. Sridhar R, Perumal PT, Etti S, Shanmugam G, Ponnuswamy MN, Prabavathy VR, Mathivanan N (2004) Design, synthesis and antimicrobial activity of 1H-pyrazolecarboxylates. Bioorg Med Chem Lett 14:6035-6040
51. Stahl E (1969) Thin-layer chromatography. Springer, New York
52. Tetko IV (2005) Computing chemistry on the web. Drug Discov Today 10:1497-1500
53. Tewari AK, Srivastava P, Singh VP, Singh A, Goel RK, Monhan CG (2010) Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity. Chem Pharm Bull 58:634-638
54. Warshakoon NC, Wu S, Boyer A, Kawamoto R, Renock S, Xu K, Pokross M, Evdokimov AG, Zhou S, Winter C, Walter R, Mekel M (2006) Design and synthesis of a series of novel pyrazolylpyridines as HIF 1-α prolyl hydroxylase inhibitors. Bioorg Med Chem Lett 16:5687-5690
55. Wei F, Zhao B-X, Huang B, Zhang L, Sun C-H, Dong W-L, Shin D-S, Miao J-Y (2006) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2′-hydroxy-3′-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate. Bioorg Med Chem Lett 16:6342-6347
56. Wei F, Zhao BX, Dong WL, Hua Z, Shin DS, Wang DW, Xia Y, Ge YQ (2007) Microwave-assisted rapid and straightforward synthesis of novel 6-(aroxymethyl)-2-aryl-6,7-dihydropyrazolo[5,1-c][1,4]oxazin-4-one derivatives. Synth Commun 37:4415-4424
57. Xia Y, Dong Z-W, Zhao B-X, Ge X, Meng N, Shin D-S, Miao J-Y (2007) Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H- pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 15:6893-6899
58. Xie YS, Pan XH, Zhao BX, Liu JT, Shin DS, Zhang JH, Zheng LW, Zhao J, Miao JY (2008) Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H) -one derivatives. J Organomet Chem 693:1367-1374
59. Xie Y-S, Zhao H-L, Su H, Zhao B-X, Liu J-T, Li J-K, Lv H-S, Wang B-S, Shin D-S, Miao J-Y (2010) Synthesis, single-crystal characterization and preliminary biological evaluation of novel ferrocenyl pyrazolo[1,5-a]pyrazin- 4(5H)-one derivatives. Eur J Med Chem 45:210-218
60. Zhang JH, Fan CD, Zhao BX, Shin DS, Dong WL, Xie YS, Miao JY (2008) Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin- 4(5H)-one derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 16:0165-10171
61. Zheng LW, Wub LL, Zhao BX, Dong WL, Miao JY (2009) Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 17:1957-1962
62. Zheng L-W, Li Y, Geb D, Zhao B-X, Liu Y-R, Lv H-S, Ding J, Miao J-Y (2010) Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Bioorg Med Chem Lett 20:4766-4770